Hyaluronic acid as an internal phase additive to obtain ofloxacin/PLGA microsphere by double emulsion method

Bio-Medical Materials and Engineering

Volumn 24, Issue 1, 2014, Pages 751-756

  Wu, Gang ^a,b   Chen, Long ^a,b   Li, Hong ^c   Wang, Ying Jun ^a,b  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b National Engineering Research Center for Tissue Restoration and Reconstruction   (China)

^c JINAN UNIVERSITY   (China)

Author keywords

Drug release; hyaluronic acid; microsphere; ofloxacin

Indexed keywords

AVERAGE PARTICLE SIZE; DRUG RELEASE; DRUG-LOADING EFFICIENCY; LASER DISTRIBUTION; LOADING EFFICIENCY; OFLOXACIN; POLY LACTIC-CO-GLYCOLIC ACID; WATER-IN-OIL-IN-WATER;

ADDITIVES; BIOMEDICAL ENGINEERING; BIOTECHNOLOGY; EMULSIFICATION; MICROSPHERES; ORGANIC ACIDS; POLYELECTROLYTES;

HYALURONIC ACID;

HYALURONIC ACID; OFLOXACIN; POLYGLACTIN;

AQUEOUS SOLUTION; CALIBRATION; CONFERENCE PAPER; DRUG ADSORPTION; DRUG RELEASE; EMULSION; ENCAPSULATION; IN VITRO STUDY; LASER DIFFRACTION; OSMOTIC PRESSURE; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

DRUG RELEASE; HYALURONIC ACID; MICROSPHERE; OFLOXACIN;

ADSORPTION; ANTI-BACTERIAL AGENTS; CALIBRATION; DRUG DELIVERY SYSTEMS; ELECTROLYTES; EMULSIONS; HYALURONIC ACID; LACTIC ACID; LASERS; MICROSPHERES; OFLOXACIN; OILS; OSMOTIC PRESSURE; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; SHEAR STRENGTH; SOLVENTS; STATIC ELECTRICITY; STRESS, MECHANICAL; WATER;

EID: 84891066848     PISSN: 09592989     EISSN: None     Source Type: Journal    
DOI: 10.3233/BME-130863     Document Type: Conference Paper

References (9)

1. Grosskopf I, Ben David A, Charach G, Hochman I, Pitlik S. Bone and joint tuberculosis-a 10-year review. Israel journal of medical sciences. 1994;30:278-83.
2. Kodmon C, Hollo V, Huitric E, Amato-Gauci A, Manissero D. Multidrug-and extensively drugresistant tuberculosis: A persistent problem in the European Union European Union and European Economic Area. Euro Surveill. 2010;15.
3. Berning SE. The role of fluoroquinolones in tuberculosis today. Drugs. 2001;61:9-18.
4. Harsha S, Rani S. Ofloxacin targeting to lungs by way of microspheres. International journal of pharmaceutics. 2009;380:127-32.
5. Tran VT, Benoît JP, Venier-Julienne MC. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy International journal of pharmaceutics. 2011;407:1-11.
6. Peltonen L, Aitta J, Hyvönen S, Karjalainen M, Hirvonen J. Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly (I) lactide nanoparticles. Aaps Pharmscitech. 2004;5:115-20.
7. Cheow WS, Hadinoto K. Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly (lactic-co-glycolic acid) nanoparticles: Modifications of standard nanoparticle preparation methods. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2010;370:79-86.
8. Nasr M, Awad GAS, Mansour S, Taha I, Shamy AA, Mortada ND. Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. European Journal of Pharmaceutics and Biopharmaceutics. 2011;79:1-11.
9. Kim K, Yu M, Zong X, Chiu J, Fang D, Seo Y-S, et al. Control of degradation rate and hydrophilicity in electrospun non-woven poly (D, L-lactide) nanofiber scaffolds for biomedical applications. Biomaterials. 2003;24:4977-85.